Evidence Strategy & Development Manager Rare & Neurology (m/f/d)

UCB S.A.; Monheim am Rhein; Hybrid; EUR 80.000 - 100.000; Vollzeit

Zusammenfassung

A global biopharmaceutical company is seeking an Evidence Strategy & Development Manager Rare & Neurology to shape and execute a comprehensive evidence generation strategy in Monheim, Germany. The ideal candidate has a medical degree, extensive experience in Medical Affairs, and a strong background in Real-World Evidence. This role focuses on driving innovative approaches, building strategic partnerships, and ensuring compliance with German regulatory requirements. Join us to create value for patients and improve healthcare outcomes.

Qualifikationen

• Several years in Medical Affairs, clinical development, or R&D, ideally in neurology and/or rare diseases.
• Expertise in Real-World Evidence, non-interventional research, publication planning, and dossier writing.
• Knowledge of German regulatory requirements, AMNOG and HTA processes, ICH-GCP guidelines.

Aufgaben

• Develop and implement a national evidence generation strategy for Rare & Neurology.
• Identify critical data gaps for assets.
• Lead Real-World Evidence programs and Post-Approval studies.
• Provide strategic medical input into global development and pipeline programs.
• Plan and execute national publication strategies.
• Build and maintain partnerships with research institutions.

Kenntnisse

Strategic thinking and scientific leadership

Strong communication skills in German and English

Ability to lead projects and collaborate cross-functionally

Innovation mindset and digital affinity

Integrity and compliance awareness

Ausbildung

M.D. preferred, Pharm.D., or natural sciences

Jobbeschreibung

Make your mark for patients

To strengthen our Rare & Epilepsy organization, we are looking for anEvidence Strategy & Development Manager Rare & Neurology (m/f/d), to be based inMonheim, Germany.

About the role

As Evidence Strategy & Development Manager Rare & Neurology (m/f/d), you will shape and execute a comprehensive evidence generation strategy for Rare & Neurology in Germany. You will lead Real-World Evidence and Post-Approval research, provide strategic input into global pipeline programs considering German HTA/AMNOG requirements, and ensure local medical needs are integrated into global studies. The role includes driving cross-functional evidence workstreams, leading publication strategy, and fostering partnerships with academic institutions while promoting innovative, digital approaches.Your mission: scientific excellence, compliance, and creating value for patients.

Who you’ll work with

You will collaborate closely with Medical Affairs, Market Access, Global Clinical Development, as well as European and global Medical and Development teams. Additionally, you will build strategic partnerships with academic institutions, networks, and external experts. This role reports directly to the Head of Medical Rare & Neurology Germany.

What you’ll do

• Develop and implement a national evidence generation strategy for Rare & Neurology
• Identify critical data gaps for our assets
• Lead Real-World Evidence programs and Post-Approval studies (NIS, IIS, registries)
• Provide strategic medical input into global development and pipeline programs to ensure German clinical practice and HTA/AMNOG requirements are reflected
• Plan and execute national publication strategies
• Build and maintain partnerships with research institutions and professional societies
• Drive innovative approaches such as digital data sources and analytics
• Represent the affiliate in European and global Evidence Generation & Pipeline networks to drive alignment and share best practices

For this role we’re looking for the following education, experience and skills:

• Education:M.D. preferred, Pharm.D., or natural sciences
• Experience:Several years in Medical Affairs, clinical development, or R&D, ideally in neurology and/or rare diseases
• Expertise:Real-World Evidence, non-interventional research, publication planning, dossier writing and scientific contribution to G-BA negotiations
• Knowledge:German regulatory requirements, AMNOG and HTA processes, ICH-GCP guidelines, local laws, and regulatory requirements
• Skills:
  • Strategic thinking and scientific leadership
  • Strong communication skills in German and English
  • Ability to lead projects and collaborate cross-functionally
  • Innovation mindset and digital affinity
  • Integrity and compliance awareness

Interested?

Apply now and join our Patient Impact team! Together, we shape the future of evidence‑based medicine and improve patient care in Germany.

Are you ready to ‘go beyond’ to create value and make your mark for patients? If this sounds like you, then we would love to hear from you!

About us

UCB is a global biopharmaceutical company, focusing on neurology and immunology. We are over 9,000 people in all four corners of the globe, inspired by patients and driven by science.

Why work with us?

At UCB, we don’t just complete tasks, we create value. We aren’t afraid to push forward, collaborate, and innovate to make our mark for patients. We have a caring, supportive culture where everyone feels included, respected, and has equal opportunities to do their best work. We ‘go beyond’ to create value for our patients, and always with a human focus, whether that’s on our patients, our employees, or our planet. Working for us, you will discover a place where you can grow, and have the freedom to carve your own career path to achieve your full potential.

At UCB, we’ve embraced a hybrid‑first approach to work, bringing teams together in local hubs to foster collaborative curiosity. Unless expressly stated in the description or precluded by the nature of the position, roles are hybrid with 40% of your time spent in the office.

UCB is an equal opportunity employer. All employment decisions will be made without regard to any characteristic protected by applicable laws.

Should you require any adjustments to our process to assist you in demonstrating your strengths and capabilities contact us on [e-mail]. Please note should your enquiry not relate to adjustments; we will not be able to support you through this channel.